Skip to main content

Table 2 Characteristics of patients with radiation-induced gliomas

From: Assessment of therapeutic outcome and role of reirradiation in patients with radiation-induced glioma

Case no.

Sex

Age (years)

Secondary disease

Karnofsky performance status

Location

Leukoencephalopathy

Comorbidity

Initial treatment

Recurrent pattern

Treatment at first recurrence

PFS (months)

OS (months)

Status

Operation

Chemotherapy

Radiation therapy

Operation

Chemotherapy

Radiation therapy

1

M

45

GBM, NOS

80

Rt. insula

Grade I

Visual dysfunction

Partial removal

ACNU

No

Local

BSC

  

28.1

34.5

Dead

2

M

45

AA, NOS

70

Rt. temporal

No

No

Partial removal

TMZ

No

Local

BSC

  

3.0

8.4

Dead

3

M

10

GBM, IDH1/2-Wildtype

80

Lt. frontal Lt. parietal

No

Short stature

Biopsy

ACNU

Local RT 40 Gy/20fr

Local

No

Carboplatin, Etoposide

No

3.8

11.0

Dead

4

M

33

GBM, IDH1/2-Wildtype

60

Rt. Cerebellum Pons (dissemination)

Grade II

Hypopituitarism

Biopsy

Carboplatin, Etoposide

No

Dissemination

BSC

  

2.5

4.6

Dead

5

F

34

GBM, IDH1/2-Wildtype

80

Lt. temporal

No

Hypopituitarism Visual dysfunction

Total removal

TMZ

No

Local

Subtotal removal

TMZ

Local RT 45 Gy/25f

11.3

27.5

Dead

6

F

39

AA, IDH1/2-Wildtype

60

Rt. Parietal Rt. occipital

No

Mild cognitive impairment

Rt. parietal: partial removal Rt. occipital: partial removal

TMZ

No

Local

Rt. Parietal: Total removal Rt. Occipital: Total removal

TMZ

Local RT 60 Gy/30fr

8.8

27.3

Dead

7

F

23

GBM, IDH1/2-Wildtype

90

Rt. frontal

No

Mild cognitive impairment

Subtotal removal

TMZ

No

Local

No

TMZ

SRT 40 Gy/10fr

7.4

29.1

Dead

8

M

17

GBM, NOS

90

Rt. parietal

No

No

Total removal

TMZ

Local RT 66 Gy/33fr

Local

No

No

GKS

17.0

30.8

Dead

9

F

32

GBM, IDH1/2-Wildtype

80

Lt. frontal-parietal

Grade II

No

Biopsy

TMZ

Local RT 60 Gy/30fr

Distant

No

TMZ

SRT 42 Gy/7fr

23.0

35.1

Dead

10

F

49

GBM, IDH1/2-Wildtype

90

Rt. frontal

No

No

Total removal

TMZ, Bev

Local RT 50 Gy/25fr

Distant

Biopsy

Bev

SRT 42 Gy/7fr

15.9

28.3

Dead

11

M

28

GBM, IDH1/2-Wildtype

60

Lt. cerebellum

No

Mild cognitive impairment

Biopsy

TMZ, Bev

Local RT 40 Gy/15fr

No recurrence

No recurrence

  

9.8

9.8

Alive

  1. M male, F female, GBM glioblastoma, NOS not otherwise specified, AA anaplastic astrocytoma, IDH isocitrate dehydrogenase, Rt right, Lt left, ACNU nimustine hydrochloride, TMZ temozolomide, Bev bevacizumab, RT radiation therapy, BSC best supportive care, GKS gamma knife radiosurgery, SRT stereotactic radiotherapy